Olaparib-Resistant BRCA2MUT Ovarian Cancer Cells with Restored BRCA2 Abrogate Olaparib-Induced DNA Damage and G2/M Arrest Controlled by the ATR/CHK1 Pathway for Survival
Article in Cells (March 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Cells (March 2023)
Article in Cancers (December 2022)
Article in Naunyn-Schmiedeberg's Archives of Pharmacology (July 2022)